SCHEMBL3633161

SCHEMBL3633161

[CH2]c1n[nH]c(C)c1Cc1ccc(OC)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP2D6 P10635 1/20 0.50
ATM Q13315 1/20 0.50
LMNA P02545 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
SLC5A1 P13866 1/20 0.47
SLC5A2 P31639 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
AR P10275 1/20 0.46
KDM4E B2RXH2 1/20 0.46
MPI P34949 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
LTA4H P09960 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
COMT P21964 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
GAA P10253 1/20 0.40
GFER P55789 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9464633 0.84 LMNA (0.63) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL1682189 0.81 SLC5A1 (0.53) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL21274894 0.81 ALDH1A1 (0.58) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL17156328 0.77 SLC5A2 (0.52) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL21274861 0.76 PTGS1 (0.45) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL21275062 0.76 PTGS1 (0.45) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL21274994 0.76 RAB9A (0.48) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL1753882 0.74 LTA4H (0.46) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL1754055 0.74 ALDH1A1 (0.42) ALDH1A1CYP2D6ATMLMNASMN1; SMN2
SCHEMBL27755987 0.73 TGFBR1 (0.44) ALDH1A1CYP2D6ATMLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2152664-A1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS Brystol-Myers Squibb Company (US) 2010-02-17 EP claimed
WO-2008157162-A1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-12-24 WO claimed
EP-1981854-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS Brystol-Myers Squibb Company (US) 2008-10-22 EP claimed
WO-2007070816-A2 THIOPHENE DERIVATIVES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO claimed
WO-2007070826-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO claimed
EP-2152664-A1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS Brystol-Myers Squibb Company (US) 2010-02-17 EP disclosed
WO-2008157162-A1 DIPEPTIDE ANALOGS AS COAGULATION FACTOR INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2008-12-24 WO disclosed
EP-1981854-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS Brystol-Myers Squibb Company (US) 2008-10-22 EP disclosed
EP-1966141-A1 SIX-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS Brystol-Myers Squibb Company (US) 2008-09-10 EP disclosed
WO-2007070818-A1 SIX-MEMBERED HETEROCYCLES USEFUL AS SERINE PROTEASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed
WO-2007070816-A2 THIOPHENE DERIVATIVES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed
WO-2007070826-A1 ARYLPROPIONAMIDE, ARYLACRYLAMIDE, ARYLPROPYNAMIDE, OR ARYLMETHYLUREA ANALOGS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-06-21 WO disclosed